Stakeholder engagement remains an important component of policy development, particularly for mechanisms that require coordination across multiple sectors and institutions.
In line with this, the Dangerous Drugs Board (DDB) recently conducted a Public Consultation on the proposed Early Warning System (EWS) for New Psychoactive Substances (NPS), bringing together representatives from government agencies, law enforcement and public safety institutions, regulatory bodies, healthcare organizations, treatment and rehabilitation centers, academic and research institutions, professional associations, industry representatives, international organizations, and interested members of the public.
The activity provided an opportunity to present the framework under consideration and gather comments and technical inputs that may contribute to its further refinement. Discussions focused on key considerations related to information exchange, monitoring processes, institutional coordination, reporting mechanisms, and operational requirements that may support the implementation of the system.
Contributions from the fields of public health, toxicology, forensic science, research, regulation, border control, law enforcement, and treatment and rehabilitation offered valuable insights on how the mechanism may function within existing institutional mandates and response frameworks.
The proposed EWS seeks to establish a structured mechanism for the timely collection, analysis, assessment, and dissemination of information on emerging substances of concern. By supporting the early identification of potential risks and facilitating coordinated information-sharing among relevant institutions, the system is envisioned to contribute to informed policy, regulatory, public health, and enforcement responses.
New Psychoactive Substances (NPS) have been known in the market by various names, including “designer drugs,” “legal highs,” “herbal highs,” and “bath salts.” Traditionally, the term “designer drugs” referred to synthetic substances specifically developed to mimic the effects of controlled drugs. Over time, however, its meaning has expanded to include a broader range of psychoactive substances that produce effects similar to those of both illicit drugs and certain prescription medications.
The insights generated through the public consultation will help inform the continuing refinement of the draft guidelines as the DDB advances efforts toward the establishment of a national EWS for NPS in the Philippines.
#DangerousDrugsBoard #BagongPilipinas
